Pharmaceuticals

Pertussis Vaccine Market 2026–2030: Forecast, Innovation, and Competitive Trends

February 17, 2026February 17, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the pertussis vaccine market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Pertussis Vaccine Market in 2026, and what figure is it projected to hit by 2030?

The pertussis vaccine market has experienced consistent growth in recent years. It is anticipated to expand from $5.65 billion in 2025 to $5.82 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 2.9%. In the past, this market’s expansion was influenced by high childhood immunization coverage, government-led national vaccination programs, historical outbreaks of whooping cough, the integration of the pertussis vaccine into routine immunization schedules, and the availability of whole-cell vaccines.

The pertussis vaccine market is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach a valuation of $6.82 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.1%. Factors contributing to this anticipated growth include heightened awareness regarding adult pertussis vaccination, an increase in recommendations for maternal immunization, improvements in vaccine safety and efficacy, wider access to healthcare in developing nations, and the progression of combination vaccine development. Key trends expected during this period involve a greater uptake of acellular pertussis vaccines, an enhanced emphasis on booster immunization strategies, the broadened availability of combination vaccines incorporating pertussis, an increase in adult and maternal pertussis vaccinations, and reinforced governmental immunization efforts.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13023&type=smp

Which Drivers Are Affecting Market Participation In The Pertussis Vaccine Market?

The increasing number of births is propelling the expansion of the pertussis vaccine market in the future. Childbirth refers to the process of a mother delivering a baby. This event represents the conclusion of pregnancy, a period where the fetus matures inside the mother’s womb, signaling the commencement of a child’s life beyond it. The pertussis vaccine is predominantly administered to children as it offers protection against whooping cough and other serious, potentially fatal illnesses. As an illustration, data from January 2023, reported by the US-based national public health entity, the Centers for Disease Control and Prevention, indicated that the United States experienced a 1% rise in recorded births, reaching a total of 3,664,292, when contrasted with the previous year, 2022. Consequently, the growing number of births is fueling the expansion of the pertussis vaccine market.

What Segment Classifications Make Up The Pertussis Vaccine Market?

The pertussis vaccine market covered in this report is segmented –

1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine

2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine

3) By Application: Children, Adults, Infants

4) By End-User: Vaccination Centers, Hospitals, Clinics

Subsegments:

1) By DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine: Pediatric DTaP Vaccine, Combination Vaccines With DTaP

2) By Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine: Adolescent Tdap Vaccine, Adult Tdap Vaccine

What Long-Term Trends Are Expected To Shape The Future Of The Pertussis Vaccine Market?

Key companies operating in the pertussis vaccine market are prioritizing the development of advanced immunization solutions and securing necessary regulatory approvals to enhance the protection of mothers and infants against whooping cough. These endeavors are focused on improving vaccine accessibility, extending its recommended use during pregnancy, and reducing pertussis-related illness in newborns. For instance, in January 2023, Sanofi S.A., a France-based biopharmaceutical company, received U.S. FDA approval for the broader use of its Adacel (Tdap) vaccine during the third trimester of pregnancy. This enables maternal immunization to help protect infants younger than two months, who are most vulnerable to severe pertussis infection. This approval empowers healthcare providers to actively immunize pregnant individuals, ensuring that protective antibodies are passed to the newborn before birth. As a result, infants gain early-life protection against pertussis, bridging the immunity gap until they can receive their own scheduled vaccinations.

Which Key Market Players Are Investing In Expansion And Innovation Within The Pertussis Vaccine Market?

Major companies operating in the pertussis vaccine market are Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline plc, Sanofi Pasteur SA, CSL Limited, Serum Institute of India, Biological E. Limited, Bharat Biotech International Limited, Panacea Biotec Limited, PT Bio Farma, Walvax Biotechnology Co. Ltd., Beijing Minhai Biotechnology Co. Ltd., Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Chiron Corporation, Sinovac Biotech Ltd., Takeda Pharmaceutical Company, Novartis AG, Johnson & Johnson

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

Which Regions Are Poised For Strategic Growth In The Pertussis Vaccine Market?

North America was the largest region in the pertussis vaccine market in 2025. The regions covered in the pertussis vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pertussis Vaccine Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13023&type=smp

Browse Through More Reports Similar to the Global Pertussis Vaccine Market 2026, By The Business Research Company

Pertussis Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

Porcine Epidemic Diarrhea Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795